Top Story

Somatostatin receptors viable markers in bronchopulmonary neuroendocrine neoplasms

January 23, 2015

Somatostatin receptors may have utility as diagnostic, prognostic and therapeutic markers of bronchopulmonary neuroendocrine neoplasms, according to research published in The Journal of Clinical Endocrinology & Metabolism.

“Bronchopulmonary neuroendocrine tumors are different in diagnostics and treatment from gastroenteropancreatic neuroendocrine tumors,” Daniel Kaemmerer, MD, of the department of general and visceral surgery at Zentralklinik Bad Berka in Germany, told Endocrine Today.

In the Journals

Temsirolimus, bevacizumab shows promise for pancreatic neuroendocrine tumors

January 22, 2015
Combination treatment with temsirolimus and bevacizumab demonstrated considerable activity and a reasonable safety profile in patients with progressive pancreatic…
Kate Nathanson In the Journals

ATRX mutation possible biomarker for rare neuroendocrine tumors

January 22, 2015
A somatic mutation in the ATP-dependent helicase, or ATRX, gene recently demonstrating potential as a molecular marker for aggressive brain tumors could also serve…

Versartis Inc. reports long-acting recombinant growth hormone extension trial data

January 11, 2015
The 12-month results from an extension study looking at long-term safety and efficacy of a novel, long-acting form of recombinant human growth hormone (rhGH) developed…
CME
Acromegaly: Challenges in Diagnosis - Part 2 of 5

Acromegaly: Pathophysiology, Signs, Symptoms, and Complications - Part 1 of 5

This activity is supported by an educational grant from Genentech.

An understanding of the pathophysiological mechanisms of acromegaly is important to its various complications as well…
More »
CME
Experts Take: Dialogue on HTG

Experts’ Take: Dialogue on Hypertriglyceridemia

This activity is supported by an independent educational grant from Amarin Pharma Inc.

Lead by genetic studies, recent data describe a causal role of triglycerides (TG) in the formation of atherosclerosis…
More »

Filter By:

In the Journals

Somatostatin receptors viable markers in bronchopulmonary neuroendocrine neoplasms

January 23, 2015
Somatostatin receptors may have utility as diagnostic, prognostic and therapeutic markers of bronchopulmonary neuroendocrine neoplasms, according to…
In the Journals

Temsirolimus, bevacizumab shows promise for pancreatic neuroendocrine tumors

January 22, 2015
Combination treatment with temsirolimus and bevacizumab demonstrated considerable activity and a reasonable safety profile in patients with…
Kate Nathanson In the Journals

ATRX mutation possible biomarker for rare neuroendocrine tumors

January 22, 2015
A somatic mutation in the ATP-dependent helicase, or ATRX, gene recently demonstrating potential as a molecular marker for aggressive brain…

Versartis Inc. reports long-acting recombinant growth hormone extension trial data

January 11, 2015
The 12-month results from an extension study looking at long-term safety and efficacy of a novel, long-acting form of recombinant human growth…
FDA approvals

FDA approves Somatuline Depot for gastroenteropancreatic neuroendocrine tumors

December 16, 2014
The FDA today approved lanreotide for treatment of patients with unresectable, well- or moderately differentiated, locally advanced or metastatic…

Signifor long-acting release wins FDA approval for acromegaly treatment

December 16, 2014
The FDA has approved a long-acting release formulation of pasireotide to treat patients with acromegaly who have either not responded to surgery…
In the Journals

Metabolic effects of TNF-a depend on intact pituitary function

December 12, 2014
With infusion of tumor necrosis factor-alpha, healthy men had greater increases in urea and amino acid fluxes and endogenous glucose production than…
Meeting News Coverage

PET/CT neuroimaging reveals pituitary abnormalities in veterans with PTSD

December 4, 2014
Hybrid neuroimaging of the pituitary region of the brain could help distinguish military veterans with posttraumatic stress disorder from those with…
In the JournalsPerspective

Gleason score associated with time to development of neuroendocrine prostate cancer

November 25, 2014
Gleason scores among patients with conventional prostatic adenocarcinoma was significantly associated with time to development of treatment-related…
In the Journals

Acromegaly diagnosis treatment, guideline issued by The Endocrine Society

November 4, 2014
A new clinical practice guideline developed by The Endocrine Society and published the Journal of Clinical Endocrinology & Metabolism addresses…
More Headlines »
morganatic-roan